TR200100177T2 - Antifungal Aktiviteye sahip bir bileşimin oral farmasötik kompozisyonu ve bu kompozisyonun hazırlanış metodu. - Google Patents
Antifungal Aktiviteye sahip bir bileşimin oral farmasötik kompozisyonu ve bu kompozisyonun hazırlanış metodu.Info
- Publication number
- TR200100177T2 TR200100177T2 TR2001/00177T TR200100177T TR200100177T2 TR 200100177 T2 TR200100177 T2 TR 200100177T2 TR 2001/00177 T TR2001/00177 T TR 2001/00177T TR 200100177 T TR200100177 T TR 200100177T TR 200100177 T2 TR200100177 T2 TR 200100177T2
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- antifungal activity
- oral pharmaceutical
- preparation
- coating
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000000843 anti-fungal effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000008203 oral pharmaceutical composition Substances 0.000 title abstract 2
- 238000000576 coating method Methods 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 2
- 239000002736 nonionic surfactant Substances 0.000 abstract 2
- 239000002356 single layer Substances 0.000 abstract 2
- 238000005507 spraying Methods 0.000 abstract 2
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Abstract
Aktif madde olarak antifungal aktiviteye sahip bir bilesimden, 50 ila 600 um partikül büyüklügüne sahip hareketsiz bir çekirdek ve püskürtme islemi ile elde edilen tek bir tabakadan ve antifungal aktiviteye sahip bir bilesimden, hidrofili polimer ve iyonik olmayan yüzey aktif maddesinden olusan bir solüsyondan meydana gelen ve anilan aktif parçayi kapsayan bir kaplamadan olusan tablet seklinde bir oral farmasötik kompozisyon. Tüm süreç boyunca sabit bir kaplama hizinda antifungal madde, hidrofilik polimer ve iyonik olmayan yüzey aktif maddesinden olusan bir solüsyonun püskürütülmesi yolu ile 50 ila 600 um arasinda bir büyüklüge sahip hareketsiz çekirdeklerle tek kat olarak kaplama islemini ve ayni aparatta anilan kaplamanin tek adimli bir kurutma islemini kapsayan metot.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801539A ES2157731B1 (es) | 1998-07-21 | 1998-07-21 | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100177T2 true TR200100177T2 (tr) | 2001-07-23 |
Family
ID=8304581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00177T TR200100177T2 (tr) | 1998-07-21 | 1999-07-20 | Antifungal Aktiviteye sahip bir bileşimin oral farmasötik kompozisyonu ve bu kompozisyonun hazırlanış metodu. |
Country Status (31)
Country | Link |
---|---|
US (1) | US6737082B1 (tr) |
EP (1) | EP1103252B1 (tr) |
JP (1) | JP4190732B2 (tr) |
KR (1) | KR100572135B1 (tr) |
AT (1) | ATE234077T1 (tr) |
AU (1) | AU750730B2 (tr) |
BG (1) | BG65187B1 (tr) |
BR (1) | BR9912300A (tr) |
CA (1) | CA2337509C (tr) |
CZ (1) | CZ291938B6 (tr) |
DE (1) | DE69905905T2 (tr) |
DK (1) | DK1103252T3 (tr) |
EE (1) | EE04415B1 (tr) |
ES (2) | ES2157731B1 (tr) |
HK (1) | HK1037531A1 (tr) |
HR (1) | HRP20010128B1 (tr) |
HU (1) | HU228895B1 (tr) |
IL (1) | IL140910A (tr) |
ME (1) | MEP26708A (tr) |
MX (1) | MXPA01000681A (tr) |
NO (1) | NO320054B1 (tr) |
NZ (1) | NZ509886A (tr) |
PL (1) | PL194740B1 (tr) |
PT (1) | PT1103252E (tr) |
RS (1) | RS50063B (tr) |
RU (1) | RU2209628C2 (tr) |
SK (1) | SK283279B6 (tr) |
TR (1) | TR200100177T2 (tr) |
UA (1) | UA64009C2 (tr) |
WO (1) | WO2000004881A1 (tr) |
ZA (1) | ZA200101293B (tr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1122456C (zh) * | 1996-01-31 | 2003-10-01 | 南亚拉巴马医学科学基金会 | 含有天然的还原叶酸盐异构体的食品和维生素制品 |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
CN1402629A (zh) | 1999-12-23 | 2003-03-12 | 辉瑞产品公司 | 提供提高的药物浓度的药物组合物 |
FR2842736B1 (fr) * | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
DK1438960T4 (da) * | 2003-01-14 | 2013-03-25 | Cimex Pharma Ag | Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed |
SI1438961T2 (sl) * | 2003-01-14 | 2014-12-31 | Cimex Pharma Ag | Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru |
FR2852607B1 (fr) * | 2003-03-20 | 2006-07-14 | Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications | |
BRPI0412734A (pt) * | 2003-07-17 | 2006-09-26 | Tibotec Pharm Ltd | processo para preparação de partìculas que contêm um antiviral |
FR2857591B1 (fr) * | 2003-07-17 | 2007-11-02 | Ethypharm Sa | Particules comprenant un principe actif sous forme de co-precipite |
FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
JP5435946B2 (ja) | 2005-08-22 | 2014-03-05 | ジョンズ ホプキンス ユニバーシティ | 疾患を処置するためのヘッジホッグ経路アンタゴニスト |
CN101283984B (zh) * | 2007-04-12 | 2010-05-26 | 永胜药品工业股份有限公司 | 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物 |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
EP2542222A2 (de) * | 2010-03-05 | 2013-01-09 | Basf Se | Schmelzüberzogene arzneiformen |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
MA40982A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
RU2017141029A (ru) * | 2015-05-25 | 2019-06-25 | Сан Фармасьютикал Индастриз Лимитед | Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки |
AU2017310506B2 (en) | 2016-08-11 | 2019-11-21 | Dmk Pharmaceuticals Corporation | Drug compositions |
WO2018098501A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
WO2019208801A1 (ja) * | 2018-04-27 | 2019-10-31 | 凸版印刷株式会社 | 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙 |
WO2023118082A1 (en) * | 2021-12-22 | 2023-06-29 | Palau Pharma, S.L.U. | Multiparticulate albaconazole composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4916134A (en) * | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
IE61651B1 (en) * | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
IL124935A (en) * | 1996-05-20 | 2001-06-14 | Janssen Pharmaceutica Nv | Dissolvable fungicidal preparations contain itraconazole with improved bioavailability |
PE68898A1 (es) * | 1996-05-24 | 1998-11-10 | Schering Corp | Composiciones antihongo con biodisponibilidad mejorada |
KR20000022294A (ko) * | 1996-06-28 | 2000-04-25 | 둘락 노먼 씨. | 트리아졸 항진균 화합물을 함유하는 경구 조성물 |
DE19626924C2 (de) * | 1996-07-04 | 1999-08-19 | Epazon B V | Gerät zur Bereitstellung eines Atemgases |
PT969821E (pt) * | 1997-03-26 | 2003-10-31 | Janssen Pharmaceutica Nv | Pastilhas tendo um nucleo revestido com um antifungico e um polimero |
-
1998
- 1998-07-21 ES ES009801539A patent/ES2157731B1/es not_active Expired - Fee Related
-
1999
- 1999-07-20 ME MEP-267/08A patent/MEP26708A/xx unknown
- 1999-07-20 BR BR9912300-2A patent/BR9912300A/pt not_active Application Discontinuation
- 1999-07-20 UA UA2001021260A patent/UA64009C2/uk unknown
- 1999-07-20 JP JP2000560874A patent/JP4190732B2/ja not_active Expired - Fee Related
- 1999-07-20 WO PCT/ES1999/000230 patent/WO2000004881A1/es not_active Application Discontinuation
- 1999-07-20 CZ CZ2001175A patent/CZ291938B6/cs not_active IP Right Cessation
- 1999-07-20 DK DK99931261T patent/DK1103252T3/da active
- 1999-07-20 CA CA002337509A patent/CA2337509C/en not_active Expired - Fee Related
- 1999-07-20 EE EEP200100041A patent/EE04415B1/xx not_active IP Right Cessation
- 1999-07-20 PT PT99931261T patent/PT1103252E/pt unknown
- 1999-07-20 IL IL14091099A patent/IL140910A/en not_active IP Right Cessation
- 1999-07-20 RS YUP-39/01A patent/RS50063B/sr unknown
- 1999-07-20 MX MXPA01000681A patent/MXPA01000681A/es active IP Right Grant
- 1999-07-20 DE DE69905905T patent/DE69905905T2/de not_active Expired - Lifetime
- 1999-07-20 US US09/744,322 patent/US6737082B1/en not_active Expired - Fee Related
- 1999-07-20 AT AT99931261T patent/ATE234077T1/de active
- 1999-07-20 ES ES99931261T patent/ES2194480T3/es not_active Expired - Lifetime
- 1999-07-20 HU HU0103708A patent/HU228895B1/hu not_active IP Right Cessation
- 1999-07-20 SK SK86-2001A patent/SK283279B6/sk not_active IP Right Cessation
- 1999-07-20 AU AU47821/99A patent/AU750730B2/en not_active Ceased
- 1999-07-20 EP EP99931261A patent/EP1103252B1/en not_active Expired - Lifetime
- 1999-07-20 PL PL99345625A patent/PL194740B1/pl not_active IP Right Cessation
- 1999-07-20 RU RU2001104894/14A patent/RU2209628C2/ru not_active IP Right Cessation
- 1999-07-20 NZ NZ509886A patent/NZ509886A/xx not_active IP Right Cessation
- 1999-07-20 KR KR1020017000783A patent/KR100572135B1/ko not_active IP Right Cessation
- 1999-07-20 TR TR2001/00177T patent/TR200100177T2/tr unknown
-
2001
- 2001-01-17 NO NO20010289A patent/NO320054B1/no not_active IP Right Cessation
- 2001-02-15 ZA ZA200101293A patent/ZA200101293B/en unknown
- 2001-02-21 BG BG105282A patent/BG65187B1/bg unknown
- 2001-02-21 HR HR20010128A patent/HRP20010128B1/xx not_active IP Right Cessation
- 2001-11-27 HK HK01108330A patent/HK1037531A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100177T2 (tr) | Antifungal Aktiviteye sahip bir bileşimin oral farmasötik kompozisyonu ve bu kompozisyonun hazırlanış metodu. | |
DK0841899T3 (da) | Præparater til topisk indgivelse af aktive bestanddele | |
AU5106996A (en) | Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby | |
ATE239454T1 (de) | Orale morphinzubereitung in teilchenform | |
EA200401085A1 (ru) | Жевательная резинка с покрытием, содержащая активное вещество местного действия | |
DE60040674D1 (de) | Silber enthaltende zusammensetzungen, geräte und verfahren zu deren herstellung | |
YU31599A (sh) | Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze | |
DE60222000D1 (de) | Sprühgetrocknete zubereitungen und verfahren für deren herstellung | |
NO980669D0 (no) | Orale raskt-opplöselige blandinger for dopaminagonister | |
MY122195A (en) | New controlled release bead, a method of producing the same and multiple unit formulation comprising it | |
ATE229327T1 (de) | Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen | |
NZ511773A (en) | Compositions and methods for treating hair and skin using aqueous delivery systems | |
FI103091B1 (fi) | Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi | |
ES2107235T3 (es) | Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina. | |
DK1077680T3 (da) | Fremgangsmåde til fremstilling af en med bånd forsynet aktivt-stof-doseringsform til prolongeret release | |
DE60133028D1 (de) | Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung | |
HUP9802498A2 (hu) | Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására | |
DE59308504D1 (de) | Retard-Form für pharmazeutische Wirkstoffe | |
DK1105099T3 (da) | Sammensætning af fiskegelatine til brug som ingrediens i tabletter | |
RU99114759A (ru) | Способ получения блокированного эпсилон-капролактамом полиизоцианата |